Skip to main content
Themis Medicare Ltd. logo

Themis Medicare Ltd. — Investor Relations & Filings

Ticker · THEMISMED ISIN · INE083B01024 LEI · 335800LHRDVIKH69AF42 BSE.NS Manufacturing
Open in API
Filings indexed 715 across all filing types
Latest filing 2026-05-29 Regulatory Filings
Country IN India
Listing BSE.NS THEMISMED

About Themis Medicare Ltd.

https://www.themismedicare.com/

Themis Medicare Ltd. is a research-driven pharmaceutical organization specializing in the development, manufacture, and marketing of a diverse range of therapeutic products. The company focuses on high-value segments including pain management, anesthesia, critical care, anti-infectives, and oncology. Its core competencies lie in the production of Active Pharmaceutical Ingredients (APIs) and complex finished dosage formulations, particularly injectables. Themis Medicare maintains a strong emphasis on Research and Development, operating state-of-the-art facilities that adhere to international quality standards such as WHO-GMP. Through strategic partnerships and a robust supply chain, the company serves both domestic and international markets, providing specialized medical solutions for hospital-based care and chronic disease management. Its portfolio includes proprietary delivery systems and differentiated generic products designed to improve patient outcomes.

Recent filings

Filing Released Lang Actions
Annual Secretarial Compliance Report for the financial year ended 31st March, 2026
Regulatory Filings Classification · 90% confidence The document is an Annual Secretarial Compliance Report issued by the Company Secretary (SAV & Associates LLP) under SEBI Listing Obligations (Regulation 24A). It is an attestation/certification of statutory and regulatory compliance, not a full annual report, earnings release, or management discussion. It primarily constitutes an officer certification rather than substantive financial data. Under the classification rules, such compliance certificates fall under Regulatory Filings (RNS).
2026-05-29 English
Copy of Newspaper Publication
Regulatory Filings Classification · 87% confidence The document is a letter to the stock exchanges submitting copies of the newspaper advertisement of the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026 (per Regulation 47 of SEBI Listing Regulations). It is not the full Annual Report or Interim Report itself but a regulatory notice/publication of results via newspaper advertisement, with links/QR codes to the full results on the website. This does not qualify as a formal Annual Report (10-K), nor a true Earnings Release (ER) or Interim Report (IR) with full financial statements — it is a compliance/regulatory announcement. No other specific category applies, so it is best classified under the general Regulatory Filings fallback (RNS).
2026-05-29 English
Newspaper Publication of Audited Standalone and Consolidated Financial Results for the quarter and year ended 31.03.2026
Earnings Release Classification · 85% confidence The document is a public notification under Regulation 47 of the SEBI Listing Regulations, consisting of a newspaper advertisement summarizing the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2020 (and similarly for other companies). It provides key highlights (total income, net profit, equity share capital, etc.) and directs readers to full results via QR code/website. This matches an initial announcement of periodical financial results rather than a comprehensive interim report or the full annual report. Therefore, it is best classified as an Earnings Release. FY 2026
2026-05-29 English
Please refer to the attachment.
Earnings Release Classification · 84% confidence The document is a Board Meeting outcome filed under SEBI Listing Regulations reporting the approval of audited standalone and consolidated financial results for the quarter and year ended 31 March 2026, along with the Auditor’s report and details on dividend recommendation and cost auditor appointment. This is an initial public announcement of periodic financial results and attached audited statements rather than a full 10-K or interim narrative report. It fits the definition of an Earnings Release (initial announcement of quarterly/periodical financial results). FY 2026
2026-05-28 English
Investor Presentation
Investor Presentation Classification · 95% confidence The document is a slide-style presentation titled “Investor Presentation” and “Result Update Presentation Q4 & FY26,” filed under Regulation 30 of SEBI. It contains financial highlights, outlook, strategy slides, and management commentary typical of investor presentations rather than an earnings release (ER) alone or a full annual/interim report. It is distributed as a deck to investors. Therefore, it is classified as an Investor Presentation (IP).
2026-05-28 English
Please refer to the Investor Presentation of the Company for the quarter ended 31.03.2026
Investor Presentation Classification · 92% confidence The document is headed “Investor Presentation” under Regulation 30 of SEBI LODR, includes slides with a business overview, Q4 & FY26 result update, consolidated financial highlights, management commentary, strategy slides, tables and charts. This matches the definition of an Investor Presentation (IP), not just an announcement or brief factsheet.
2026-05-28 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.